Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Clinical trial NCT00127881 · TERMINATED
Trial details
- NCT number
- NCT00127881
- Sponsor
- Emergent Product Development Seattle LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2014-02-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.